LITS NASDAQ Week ended 24 Jul 2026

Weekly Investor Report

Lite Strategy, Inc. · Healthcare · Biotechnology

Open interactive chart View report data
Latest close 0.99 USD
0.2% latest week
Weekly setup

Mixed setup

The weekly trend is not active. Price is -11.0% below the Trend Line and sits at 4.8% of its 52-week range. The latest completed week returned 0.2%, after a 10.1% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive. Options positioning is bullish with 37/100 conviction, while the latest news-sentiment score is 57/100. Near-term considerations: volume confirmation is below normal; earnings are due in 59d.

Setup score 27 out of 100
Latest Close 0.99 USD 24 Jul 2026
1W Return 0.2% latest completed week
4W Return 10.1% short-term follow-through
12W Return -12.5% quarterly tape
Trend Breadth 15.4% 8 of 52 weeks active
Volume Ratio 0.5x vs 13-week average
What is working
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • Next-week expectancy is negative at 37.80% based on similar historical setup states.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 0.2% Latest completed week; four-week move 10.1%. Indicator stack 8/77 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Recent Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Negative 37.80% Historical one-week expectancy contributes to the evidence score when direction is confirmed. Options pressure Bullish 37/100 conviction; expected move 56.4%. News sentiment 57/100 33 relevant articles in the latest sentiment read. Event risk 59d Next report is scheduled for 28 Sep 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is -11.0% below the Trend Line and sits at 4.8% of its 52-week range. The latest completed week returned 0.2%, after a 10.1% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.5x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
30 Jan 6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.0412-week average 0.05

12-week confirmation

Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure10/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.04Current proprietary activity-pressure read.
Buy signals1Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 10.1% over four weeks, -12.5% over 12 weeks, and -85.3% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W0.2%
4W10.1%
12W-12.5%
26W-22.2%
52W-85.3%
Active trend streak0 weeks
Active weeks in one year8
Trend breadth15.4%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure0.21Latest activity-pressure read.
Pressure change295.9%Four-week change in activity pressure.
Leadership-52.31Latest relative-leadership reading.
RS change18.4%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 30 Jun 2025 Field coverage 67% Model confidence 64%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength54/100Blend of value, momentum, and quality. Underlying universe rank 47; rank 1 is best.
Value51/100Relative valuation strength. Underlying universe rank 50; rank 1 is best.
Quality49/100Profitability and accounting quality. Underlying universe rank 52; rank 1 is best.
Momentum51/100Medium-term price momentum. Underlying universe rank 50; rank 1 is best.
Growth51/100Revenue and earnings growth. Underlying universe rank 50; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
-
Price divided by trailing earnings.
Price / sales
-
Market value relative to trailing revenue.
EV / EBITDA
-
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
-39.9%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
-
Gross profit retained from each unit of revenue.
Operating margin
-
Operating profit retained from revenue.
Free-cash-flow margin
-
Free cash flow generated from revenue.
Return on invested capital
-
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
-
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-
Latest one-year free-cash-flow growth.
Piotroski F-score
2/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
0.0%
Cash dividends relative to market value.
Buyback yield
0.0%
Net share repurchases relative to market value.
Shareholder yield
0.0%
Dividend yield plus net buyback yield.
Net debt / EBITDA
0.6x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningBullish

LITS shows bullish options pressure with a 37/100 conviction score, put-call volume ratio of 0.41, expected move of 56.4%, and Sharemaestro trend signal inactive.

Conviction37/100
Expected move56.4%
Put/call volume0.41
Pressure54
Speculation22
Volatility96
Trend agreement0
Open options detail
Insider activity-

No recent insider transactions are stored for this company.

News sentiment57/100

Weighted news tone is neutral across 33 relevant articles.

11 positive · 19 neutral · 3 negative
Patient CapitalRecent

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

Recent buy signal in the last 8 weeks
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings59dNext report is scheduled for 28 Sep 2026; event risk rises as the date approaches.
Options expected move56.4%Nearest-chain priced movement where available.
52-week drawdown-85.6%Distance below the 52-week high.
13-week volatility9.4%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher13 of 2612 weeks finished lower.
Best week+11.7%Week of 19 Jun.
Worst week-25.9%Week of 5 Jun.
Latest week+0.2%Week of 24 Jul.

Shape of recent returns

Strong gains6
Modest gains7
Flat weeks1
Modest losses4
Sharp losses8
Recent vol9.4%13-week weekly-return volatility.
Base vol9.6%52-week weekly-return volatility.
Up/down split21/29Count of positive and negative weeks in the 52-week window.
Average skew5.1% / -9.2%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape23/100

Trend, activity pressure, participation, and risk combine to a 23/100 tape read.

 Indicator analysis26/100

Latest 12-week confirmation: trend 0/12, activity pressure 10/12, relative leadership 0/12.

Activity pressure 0.04; No reversal markers Next-Week ExpectancyNegative 37.80%

Next-week expectancy is negative with a 37.80% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors50/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 50 Patient CapitalRecent

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

Recent buy signal in the last 8 weeks Options40/100

LITS shows bullish options pressure with a 37/100 conviction score, put-call volume ratio of 0.41, expected move of 56.4%, and Sharemaestro trend signal inactive.

Bullish · Call-side pressure · Expected move 56.4% Sentiment57/100

Weighted news tone is neutral across 33 relevant articles.

Q1 Earnings Highs And Lows: Natera (NASDAQ:NTRA) Vs The Rest Of The Biotechnology Stocks Insiders50/100

No recent insider transaction evidence is stored.

 Earnings59d

Next report is scheduled for 28 Sep 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
24 Jul 20260.99 USD0.2%1.11 USD3.02 USD0.21-52.31863.3KOff
17 Jul 20260.99 USD-2.3%1.12 USD3.05 USD0.13-56.08817.8KOff
10 Jul 20261.01 USD6.3%1.14 USD3.08 USD0.08-59.14693.7KOff
3 Jul 20260.95 USD5.8%1.16 USD3.11 USD-0.08-61.61995.8KOff
26 Jun 20260.90 USD8.5%1.18 USD3.14 USD-0.11-64.111.3MOff
19 Jun 20260.83 USD11.7%1.22 USD3.16 USD0.07-69.053.1MOff
12 Jun 20260.74 USD-1.0%1.25 USD3.19 USD0.29-72.011.6MOff
5 Jun 20260.75 USD-25.9%1.29 USD3.22 USD0.67-71.564.1MOff
29 May 20261.01 USD-5.6%1.33 USD3.26 USD0.96-63.942.4MOff
22 May 20261.07 USD-8.5%1.37 USD3.29 USD0.93-61.272.2MOff
15 May 20261.17 USD-4.1%1.40 USD3.32 USD0.82-57.722.2MOff
8 May 20261.22 USD8.0%1.42 USD3.35 USD0.56-56.562.4MOff
1 May 20261.13 USD-4.2%1.47 USD3.37 USD0.20-58.06869.1KOff
24 Apr 20261.18 USD0.0%1.51 USD3.40 USD0.15-56.061.4MOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.